A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonistDavid Kudrow, Eric Pearlman, Jack Semler et al.|Headache The Journal of Head and Face Pain|2022Cited by 13